News
What’s new in lung and colorectal cancer? reports from ESMO 2021
New research findings presented at ESMO 2021 show progress in adjuvant treatment for non-small-cell lung cancer (NSCLC), a novel inhibitor for HER2+ NSCLC patients, and the latest from the FOCUS…
Dexamethasone helps cancer patients with non-immunogenic tumours survive longer after surgery
Patients with non-immunogenic cancers, such as breast and gynaecological cancers, who are given the anti-nausea drug dexamethasone during surgery survive longer. The study, abstract 4224, presented at the Anesthesiology 2021…
What’s new in supportive care? presentations from ESMO 2021
Supportive care studies presented at ESMO Congress 2021 highlight the urgent need for survivors to get more support to tackle long-term symptoms and for doctors and patients to get up…
Round-up of prostate and breast cancer studies from ESMO 2021
The 2021 Congress of the European Society for Medical Oncology (ESMO), held 16‒21 September, featured studies that are likely to impact a broad spectrum of clinical practice. We summarise some…
Guiding principles for developing European comprehensive cancer networks proposed
The European Cancer Organisation and Organisation of European Cancer Institutes have put forward key principles to guide the development of a European Network of Comprehensive Cancer Centres. In a position…
Cancer World Editor heads new AACR cancer prevention working group
Adriana Albini, Editor in Chief of Cancer World, has been appointed Chair of the new Cancer Prevention Working Group (CPWG) of the American Association for Cancer Research (AACR). “I’m so…
Low risk prostate cancer: real-world data reveals high rates of switching from surveillance to treatment
Over half of men initially managed with active surveillance (AS) for ‘low risk’ prostate cancer switch within four years to definitive treatments (e.g., surgery or radiation therapy). The Canadian study,…
Careers of women in oncology hit by Covid-19 pandemic
The pandemic has seen the careers of female physicians working in oncology suffer as they have taken on more domestic responsibilities during lockdowns. Recent studies have indicated the trend may…
Blood pressure drugs improve survival in colorectal cancer
Common Blood pressure drugs may improve survival in colorectal cancer (CRC). The study, published in Cancer Medicine, (August issue), showed use of Angiotensin Converting Enzyme (ACE) inhibitors, beta blockers and…
Cancer community fights back against Covid-19 related delays
The European Cancer Organisation is making materials available to download in 30 different languages to help advocates across Europe lobby national governments to tackle the Covid-19 threat to cancer services…